Loss of Heterozygosity

specific

A genetic variation where gain, loss, or exchange of DNA results in monoallelic loss of function mutations in a diploid cell. In the context of tumor suppressor genes, where a single copy is sufficient for functionality, loss of function for the second allele is associated with tumorigenesis.

47

Centers

0

Active Trials

$14M

Cancer Funding

Top Centers for Loss of Heterozygosity(47)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
68.2
2
NCI Comprehensive
Active Research Program
67.4
3
NCI Comprehensive
Active Research Program
66.7
466.0
565.2
6
NCI Comprehensive
Active Research Program
64.5
7
NCI Comprehensive
Active Research Program
63.7
8
NCI Comprehensive
Active Research Program
63.0
9
NCI Comprehensive
Active Research Program
62.2
10
NCI Comprehensive
47.7
11
NCI Comprehensive
47.7
12
NCI Comprehensive
47.7
1347.7
14
NCI Comprehensive
47.7
1547.7
16
NCI Comprehensive
47.7
17
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
47.7
18
NCI Comprehensive
47.7
19
NCI Comprehensive
47.7
20
NCI Comprehensive
47.7
21
NCI Comprehensive
47.7
22
NCI Comprehensive
47.7
23
NCI Comprehensive
47.7
2447.7
25
NCI Comprehensive
47.7
2647.7
27
NCI Comprehensive
47.7
2847.7
2947.7
3047.7
31
NCI Comprehensive
47.7
3247.7
3347.7
3447.7
3547.7
36
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
47.7
37
NCI Comprehensive
47.7
3847.7
3947.7
4047.7
4147.7
4247.7
4347.7
4447.7
4547.7
4647.7
4747.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →